Mangoceuticals, Inc. (MGRX)
NCM – Real Time Price. Currency in USD
0.38
+0.01 (1.78%)
At close: Jun 26, 2026, 4:00 PM EDT
0.35
-0.03 (-6.72%)
After-hours: Jun 26, 2026, 7:52 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
0.38
+0.01 (1.78%)
At close: Jun 26, 2026, 4:00 PM EDT
0.35
-0.03 (-6.72%)
After-hours: Jun 26, 2026, 7:52 PM EDT
No Data
There are no news for this stock.
Total debt $294.0K significantly exceeds cash reserves ($174.6K), raising financial stability concerns
Total current liabilities $737.6K surpass Total current assets $212.5K, signaling liquidity issues
Debt-to-equity ratio (0.0) is well below the industry average (1.2), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.29 | 2.19 | 3.0 | |
| Quick ratio | 0.29 | 1.96 | 3.0 | |
| Debt to Equity | 0.02 | 1.16 | 9.0 | |
| Debt to Assets | 0.02 | 2.94 | 9.0 | |
| Interest coverage | N/A | -28.30 | 1.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 9K | 731K | 616K | 456K | 415K |
| Gross Profit | 5K | 432K | -342K | -2M | -1M |
| Operating Income | -2M | -9M | -9M | -19M | -18M |
| Net Income | -2M | -9M | -9M | -21M | -19M |
| EBITDA | -2M | -9M | -8M | -17M | -16M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -28.07 | -22.87 | N/A | 13.17 | 2.8 |
| Y/Y | -37.9 | 29.68 | N/A | 4.59 | 4.0 |
| 3y average | 2680.47 | -164.21 | N/A | -131.17 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |